Access
To read this story in full you will need to login or make a payment (see right).
Correspondence
Nature 457, 532 (29 January 2009) | doi:10.1038/457532a; Published online 28 January 2009
Open Innovation Challenges
-
Direct Molecular Detection of Proteins and Nucleic Acids
This Challenge is looking for novel approaches to protein and nucleic acid detection. This is an Id...
-
Single-cell Analysis Platform
This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...
- More Challenges
- Powered by:
nature jobs
Dermapathologist
- Indiana University School of Medicine
- Indiana, USA
Laboratory Technician (Pharmaceutical Analysis & Quality Control)
- Alliance Institute of Advanced Pharmacy and Health Sciences
- Hyderabad 500038 India
Risks and benefits may turn out to be finely balanced
Simon J. Williams1 & Paul Martin2
- Department of Sociology, University of Warwick, Coventry CV4 7AL, UK
Email: s.j.williams@warwick.ac.uk - Institute for Science and Society, University of Nottingham, University Park, Nottingham NG7 2RD, UK
Henry Greely and colleagues' Commentary (Nature 456, 702–705; 2008) is the latest in a series of expert-led deliberations on the prospects and implications of cognitive-enhancing drugs (see, for example, refs 1, 2, 3). Much of the debate on enhancement, as illustrated by the Commentary, is highly speculative and rests on assumptions that are not well grounded in evidence or experience.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
A medical view of potential adverse effectsNature Correspondence (29 Jan 2009)
Much ado about cognitive enhancementNature Correspondence (29 Jan 2009)
Patterns of drug use have varied throughout historyNature Correspondence (29 Jan 2009)
Recall of learned information may rely on taking drug againNature Correspondence (29 Jan 2009)
Careful use helps me do better research, and society benefitsNature Correspondence (29 Jan 2009)
